Cell-Easy

Cell-Easy is a Contract Development and Manufacturing Organization (CDMO) for cell therapy, focusing on preclinical and clinical drug development projects. Cell-Easy’s goal is to significantly reduce the manufacturing costs of stem cells, starting with ASC (historical and locally strong expertise), to address the affordability challenges currently faced in cell therapy. Our ASC production process is designed using a QbD approach and economic studies (manufacturing cost model simulations) to ensure cell quality, scalability, compatibility with GMP requirements, and economic viability throughout clinical development, including commercialization.